Greenwich LifeSciences, Inc. (GLSI)
NASDAQ: GLSI · Real-Time Price · USD
11.92
-0.43 (-3.48%)
At close: Aug 13, 2025, 4:00 PM
12.00
+0.22 (1.87%)
Pre-market: Aug 14, 2025, 8:11 AM EDT
Greenwich LifeSciences Market Cap
Greenwich LifeSciences has a market cap or net worth of $159.35 million as of August 14, 2025. Its market cap has decreased by -23.49% in one year.
Market Cap
159.35M
Enterprise Value
154.73M
1-Year Change
-23.49%
Ranking
Category
Stock Price
$11.92
Market Cap Chart
Since the IPO on September 25, 2020, Greenwich LifeSciences's market cap has increased from $68.69M to $159.35M, an increase of 131.99%. That is a compound annual growth rate of 18.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 165.10M | 11.84% |
| Dec 31, 2024 | 147.61M | 9.21% |
| Dec 29, 2023 | 135.16M | -30.79% |
| Dec 30, 2022 | 195.29M | -38.84% |
| Dec 31, 2021 | 319.29M | -31.08% |
| Dec 31, 2020 | 463.30M | 574.50% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |